Immatics N.V. (IMTX)
NASDAQ: IMTX · Real-Time Price · USD
4.255
-0.085 (-1.96%)
At close: May 9, 2025, 4:00 PM
4.240
-0.015 (-0.35%)
After-hours: May 9, 2025, 4:41 PM EDT
Immatics Employees
As of December 31, 2024, Immatics had 682 total employees, including 554 full-time and 128 part-time employees. The number of employees increased by 147 or 27.48% compared to the previous year.
Employees
682
Change (1Y)
147
Growth (1Y)
27.48%
Revenue / Employee
$236,564
Profits / Employee
$23,102
Market Cap
515.37M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 94,300 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
IMTX News
- 18 days ago - Immatics Announces Upcoming Oral and Poster Presentation on IMA203 TCR T-cell Therapy at 2025 ASCO Annual Meeting - GlobeNewsWire
- 6 weeks ago - Immatics N.V.: Trading Below Cash, But Not Without Reason - Seeking Alpha
- 6 weeks ago - Immatics Announces Full Year 2024 Financial Results and Business Update - GlobeNewsWire
- 6 months ago - Immatics Announces Third Quarter 2024 Financial Results, Business Update and First Clinical Data on TCER® IMA402 Targeting PRAME - GlobeNewsWire
- 6 months ago - Immatics Announces Multiple Presentations at the 39th Annual Meeting of the Society for Immunotherapy of Cancer (SITC) on TCR-T Therapy Candidates Targeting PRAME - GlobeNewsWire
- 7 months ago - Immatics: A Promising TCR Pipeline - Seeking Alpha
- 7 months ago - Immatics Announces Pricing of $150 Million Public Offering - GlobeNewsWire
- 7 months ago - Why Is Cancer-Focused Immatics Stock Trading Lower On Thursday? - Benzinga